The Dow Jones Industrial Average is pointed down this morning after Speaker of the House Nancy Pelosi (D-California) announced an inquiry into the impeachment of President Donald Trump.
Today, I'm going to discuss why this new impeachment inquiry is such an important deal for the markets…and a huge gamble for Washington Democrats.
The Dow Jones today will face downward pressure despite the likelihood of lower Fed rates.
It seems that no matter what the central bank does with rates on Wednesday, a large swath of people will criticize the decision.
While a rate hike is expected, the central bank is unlikely going to hint at any future moves on interest rates and policy.
by Greg Miller
Last week, The New York Times ran an editorial piece with the headline, "Do We Really Want a Microsoft of Marijuana?"
The author of the report, Christopher Caldwell, opines that the SAFE Banking Act would disproportionately help giant operators at the expense of smaller companies. That, in turn, would usher in a dystopian future in which multinational businesses develop new flavors and products to turn America's children into a nation of potheads.
I read a lot of wrongheaded news and misinformation pieces about cannabis, but this one may be the winner in terms of getting things wrong.
In barely 1,000 words, the author makes three points that need addressing.
The first is the overall theme. We absolutely want a Microsoft of marijuana!
We want one as investors, as consumers, and as supporters of the industry. Microsoft has its flaws, but overall, a lot of people have benefited from the success of the tech company. We can partially thank Microsoft for reliable computer operating systems, sophisticated spreadsheets, and cheap cloud computing that allows us to share our ideas in real time all over the world.
Do we want a company with the resources to improve the accuracy and speed of cannabis testing, one that can grow more precise strains for medical patients, and one that can perfect security and seed-to-sale tracking?
I want those things. So do you.
And he doesn't know it yet, but so does Mr. Caldwell. Here's why… Full Story
And he doesn't know it yet, but so does Mr. Caldwell. Here's why... Full Story
The Dow Jones Industrial Average is down Wednesday morning after the yield curve inverted the most since 2007, stoking recession fears.
The Dow Jones has lost more than 1,000 points since this time last month, and the S&P 500 is down 2.4% for the same time period.
According to the National Institute for Cannabis Investors, 2019 is turning into the best year yet for CBD companies, and today we're bringing you the three best CBD stocks to buy now.
In fact, the CBD market is set to grow by over 3,000% in the next three years.
One of our best CBD stocks to buy now is poised to gain 172% over the next year.
And that’s because the CBD industry is about to explode.
In fact, it’s expecting 3,623% growth in just under three years.
The CBD market is already valued at $591 million since being legalized in the United States in December 2018.
But the Brightfield Group says this figure will soar to $22 billion by 2022.
This type of explosive growth is precisely why we’re so bullish on CBD stocks and the cannabis sector as a whole.
The Dow Jones today will see more gains after Federal Reserve Chair Jerome Powell suggested the U.S. central bank will cut interest rates during its July meeting.
Powell has faced pressure from President Donald Trump, who has argued that rate cuts will not drive significant inflation.
Trump wants to slash borrowing costs in order to help expand the U.S. economy.
2019 is a massive year for CBD.
by Daniel Smoot
The CBD industry has been booming in 2019. Yet, it’s far from over.
In fact, it’s expected to rocket another 3,623% over the next three years.
And that’s why Money Morning is bringing you the best CBD stocks to buy today…
